SCHEMBL8523992

SCHEMBL8523992

CNS(=O)(=O)c1cccc(N(C)C(=N)Nc2cc(Br)ccc2Br)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 6/20 0.38
SIGMAR1 Q99720 2/20 0.38
EGFR P00533 3/20 0.35
ATM Q13315 1/20 0.34
LMNA P02545 2/20 0.34
PTBP1 P26599 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 2/20 0.33
THRB P10828 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
BLM P54132 1/20 0.33
BTK Q06187 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6720936 0.89 SIRT2 (0.39) SIGMAR1LMNAMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL7208229 0.88 SIGMAR1 (0.40) SIGMAR1LMNAMEN1KMT2AALDH1A1
SCHEMBL8204758 0.80 SIGMAR1 (0.43) SIGMAR1LMNAMEN1KMT2AALDH1A1
SCHEMBL8519145 0.78 TNNI3K (0.47) TNNI3KEGFRLMNAPTBP1MEN1
SCHEMBL6727640 0.77 SIGMAR1 (0.63) SIGMAR1LMNAMEN1KMT2ATSHR
SCHEMBL6728082 0.77 SIGMAR1 (0.40) SIGMAR1LMNAMEN1KMT2AALDH1A1
SCHEMBL6724377 0.76 GRIK1 (0.41) SIGMAR1ATMLMNAMEN1KMT2A
Hydrochloric Acid SCHEMBL7204073 0.76 SIGMAR1 (0.64) SIGMAR1LMNAMEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL7207132 0.76 SIGMAR1 (0.41) SIGMAR1LMNAMEN1KMT2AALDH1A1
SCHEMBL6728580 0.75 SIGMAR1 (0.39) SIGMAR1LMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO claimed